Citations

Clear

5 citation(s) found for "Permezel, Fiona".

Tremor and disability outcomes following deep brain stimulation for multiple sclerosis-associated tremor
Banks, Samantha A. , Permezel, Fiona E., Jackson, Lauren , Tobin, W. Oliver , Kantarci, Orhun H. , Keegan, B. Mark , Miller, Kai J. , Klassen, Bryan T. , Baker, Matthew R , Flanagan, E P , Tobin, W Oliver , Keegan, B Mark , Pittock, Sean J , Banks, Samantha , Baker, Matthew , Flanagan, Eoin P.

Mayo Clinic

Multiple Sclerosis Journal | October 27, 2025 | Volume: 31 | Issue: 13 | Pages: 1583-1590

10.1177/13524585251387935 | PMID 41143324 Get It

Background: Tremor in multiple sclerosis (MS) is often refractory to medications. Deep brain stimulation (DBS) may help, but possible side effects and disease exacerbation limit its use. Objectives: Evaluate outcomes of DBS for MS-associated tremor. Methods: Retrospective review of 18 patients with MS-associated tremor who underwent DBS, analyzing Expanded Disability Status Scale (EDSS) and Fahn–Tolosa–Marin (FTM) tremor scores. Results: Median age at surgery was 49.5 years (range, 28–75), with postoperative follow-up 2.5 years (range, 0–22). No relapses (0/18) or new lesions (0/8) occurred postoperatively. All had ventral intermediate nucleus leads; other targets were not used in programming. EDSS remained stable (median 6 to 6.25; p = 0.2). FTM scores improved (median 14.5 to 10, p = 0.008). Patients with EDSS 3.5–6 had variable outcomes ( p = 0.02). Conclusions: DBS is a potential treatment for severe MS tremor and did not provoke relapse. Targeting VIM alone may optimize tremor control and maintain magnetic resonance imaging (MRI) access.
Tremor and Disability Outcomes After Deep Brain Stimulation for Multiple Sclerosis-associated Tremor (P12-1.014)
Permezel, Fiona , Jackson, Lauren , Kantarci, Orhun H. , Keegan, Mark , Pittock, Sean J, Miller, Kai J. , Klassen, Bryan T. , Banks, Samantha A. , Baker, Matthew , Flanagan, Eoin P. , Tobin, W. Oliver , Pittock, Sean J.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210835 Get It

Principles of Stereotactic Surgery
Jensen, Michael A. , Neimat, Joseph S. , Kerezoudis, Panagiotis , Ali, Rushna , Halpern, Casey H. , Ojemann, Steven , Ponce, Francisco A. , Lee, Kendall H. , Haugen, Laura M., Permezel, Fiona , Klassen, Bryan T. , Miller, Kai J. , Permezel, Fiona E , Klassen, Bryan T , Kondziolka, Douglas , Miller, Kai J , Ali, Rushna , Jensen, Michael A , Richardson, Robert Mark , Kondziolka, Douglas

Mayo Clinic

Operative Neurosurgery | December 3, 2024 | Volume: 28 | Issue: 3 | Pages: 303-321

10.1227/ons.0000000000001422 | PMID 39627171 Get It

BACKGROUND AND OBJECTIVES: Stereotactic procedures are used to manage a diverse set of patients across a variety of clinical contexts. The stereotactic devices and software used in these procedures vary between surgeons, but the fundamental principles that constitute safe and accurate execution do not. The aim of this work is to describe these principles to equip readers with a generalizable knowledge base to execute and understand stereotactic procedures. METHODS: A combination of a review of the literature and empirical experience from several experienced surgeons led to the creation of this work. Thus, this work is descriptive and qualitative by nature, and the literature is used to support instead of generate the ideas of this framework. RESULTS: The principles detailed in this work are categorized based on 5 clinical domains: imaging, registration, mechanical accuracy, target planning and adjustment, and trajectory planning and adjustment. Illustrations and tables are used throughout to convey the concepts in an efficient manner. CONCLUSION: Stereotactic procedures are complex, requiring a thorough understanding of each step of the workflow. The concepts described in this work enable functional neurosurgeons with the fundamental knowledge necessary to provide optimal patient care.
Centromedian thalamic deep brain stimulation for idiopathic generalized epilepsy: Connectivity and target optimization
Park, Sihyeong , Permezel, Fiona , Agashe, Shruti , Osman, Gamaleldin , Simpson, Hugh D. , Miller, Kai J. , Gompel, Jamie J. Van , Starnes, Keith , Lundstrom, Brian N. , Worrell, Gregory A. , Gregg, Nicholas M. , Van Gompel, Jamie J , Worrell, Gregory A , Lundstrom, Brian Nils , Gregg, Nicholas M , Agashe, Shruti H , Starnes, Donnie Keith , Park, Sihyeong

Mayo Clinic

Epilepsia | September 14, 2024 | Volume: 65 | Issue: 11 | Pages: No page available

10.1111/epi.18122 | PMID 39276007 Get It

Abstract There are limited treatment options for individuals with drug‐resistant idiopathic generalized epilepsy (IGE). Small, limited case series suggest that centromedian thalamus deep brain stimulation (CM‐DBS) may be an effective treatment option. The optimal CM‐DBS target for IGE is underexamined. Here, we present a retrospective analysis of CM‐DBS targeting and efficacy for five patients with drug‐resistant IGE. Volume of tissue activated (VTA) overlap with CM nucleus was performed using an open‐source toolbox. Median follow‐up time was 13 months. Median convulsive seizure frequency reduction was 66%. One patient had only absence seizures, with >99% reduction in absence seizure frequency. Four patients had electrode contacts positioned within the CM nucleus target, all of whom had >50% reduction in primary semiology seizure, with 85% median seizure reduction ( p = .004, paired‐sample t test). Volumetric “sweet‐spot” mapping revealed that best outcomes were correlated with stimulation of the middle ventral CM nucleus. Connectivity strength between the sweet‐spot region and central peri‐Rolandic cortex was increased significantly relative to other cortical regions ( p = 8.6 × 10 −4 , Mann–Whitney U test). Our findings indicate that CM‐DBS can be an effective treatment for patients with IGE, highlight the importance of accurate targeting and targeting analysis, and within the context of prior work, suggest that ideal CM‐DBS targets may be syndrome specific.
Brain Networks Involved in Sensory Perception in Parkinson’s Disease: A Scoping Review
Permezel, Fiona , Alty, Jane , Harding, Ian H. , Thyagarajan, Dominic

Mayo Clinic

Brain Sciences | November 6, 2023 | Volume: 13 | Issue: 11 | Pages: 1552

10.3390/brainsci13111552 | PMID 38002513 Get It

Parkinson’s Disease (PD) has historically been considered a disorder of motor dysfunction. However, a growing number of studies have demonstrated sensory abnormalities in PD across the modalities of proprioceptive, tactile, visual, auditory and temporal perception. A better understanding of these may inform future drug and neuromodulation therapy. We analysed these studies using a scoping review. In total, 101 studies comprising 2853 human participants (88 studies) and 125 animals (13 studies), published between 1982 and 2022, were included. These highlighted the importance of the basal ganglia in sensory perception across all modalities, with an additional role for the integration of multiple simultaneous sensation types. Numerous studies concluded that sensory abnormalities in PD result from increased noise in the basal ganglia and increased neuronal receptive field size. There is evidence that sensory changes in PD and impaired sensorimotor integration may contribute to motor abnormalities.